Welcome to Kidney Cancer Care

Welcome to the McMaster University - St. Joseph’s Healthcare Kidney Cancer Centre of Excellence (KCCE) website. This is a patient-oriented portal providing information and links regarding the cutting edge management of kidney cancer. Here you will find up-to-date information about kidney cancer and its treatment, recent advances in management, current clinical research information, and links to our basic science research program. We hope you find this website informative and useful and we welcome your feedback.

Anil Kapoor, MD, FRCSC
Director
McMaster – SJH Kidney Cancer Centre of Excellence (KCCE)

Get the Flash Player to see this player.

 
What’s new in Kidney Cancer Care
December 19th, 2016
Statin use in patients with kidney cancer improved cancer-specific survival and overall survival, according to the results of a meta-analysis published recently in Cancer Treatment Reviews. There was, however, no effect on recurrence-free or progression-free survival
November 16, 2016
Among patients with intermediate- or poor-risk metastatic renal cell carcinoma (mRCC), first-line therapy with cabozantinib was superior to standard-of-care sunitinib with respect to objective response rate and progression-free survival, according to a study published in the Journal of Clinical Oncology
October 14th, 2016
Patients with aggressive forms of metastatic renal cell carcinoma (RCC) benefited more from treatment with cabozantinib (Cometriq) than with sunitinib (Sutent), according to a study reported here.